My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 340

    1.

    Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide.

    Alleva DG, Gaur A, Jin L, Wegmann D, Gottlieb PA, Pahuja A, Johnson EB, Motheral T, Putnam A, Crowe PD, Ling N, Boehme SA, Conlon PJ.

    Diabetes. 2002 Jul;51(7):2126-34.PMID: 12086942 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

    Daniel D, Gill RG, Schloot N, Wegmann D.

    Eur J Immunol. 1995 Apr;25(4):1056-62.PMID: 7537670 [PubMed - indexed for MEDLINE]Related articles

    3.

    Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.

    Geluk A, van Meijgaarden KE, Roep BO, Ottenhoff TH.

    J Autoimmun. 1998 Aug;11(4):353-61.PMID: 9776713 [PubMed - indexed for MEDLINE]Related articles

    4.

    A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.

    Chaturvedi P, Agrawal B, Zechel M, Lee-Chan E, Singh B.

    J Immunol. 2000 Jun 15;164(12):6610-20.PMID: 10843721 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).

    Daniel D, Wegmann DR.

    Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):956-60.PMID: 8570667 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    7.

    Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics.

    Ejrnaes M, Videbaek N, Christen U, Cooke A, Michelsen BK, von Herrath M.

    J Immunol. 2005 Mar 1;174(5):2746-55.PMID: 15728483 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.

    Maron R, Melican NS, Weiner HL.

    J Autoimmun. 1999 Jun;12(4):251-8.PMID: 10330296 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain.

    Schloot NC, Willemen S, Duinkerken G, de Vries RR, Roep BO.

    J Autoimmun. 1998 Apr;11(2):169-75.PMID: 9650096 [PubMed - indexed for MEDLINE]Related articles

    10.

    Peptides derived from murine insulin are diabetogenic in both rats and mice, but the disease-inducing epitopes are different: evidence against a common environmental cross-reactivity in the pathogenicity of type 1 diabetes.

    Heath VL, Hutchings P, Fowell DJ, Cooke A, Mason DW.

    Diabetes. 1999 Nov;48(11):2157-65.PMID: 10535449 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.

    Quinn A, McInerney B, Reich EP, Kim O, Jensen KP, Sercarz EE.

    J Immunol. 2001 Mar 1;166(5):2982-91.PMID: 11207247 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.

    Trembleau S, Penna G, Gregori S, Magistrelli G, Isacchi A, Adorini L.

    J Immunol. 2000 Dec 15;165(12):6748-55.PMID: 11120794 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.

    Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, Salzsieder E.

    Biochem Biophys Res Commun. 2003 May 2;304(2):378-84.PMID: 12711326 [PubMed - indexed for MEDLINE]Related articles

    14.

    CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.

    Akhtar I, Gold JP, Pan LY, Ferrara JL, Yang XD, Kim JI, Tan KN.

    J Exp Med. 1995 Jul 1;182(1):87-97.PMID: 7790825 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.

    Gallichan WS, Balasa B, Davies JD, Sarvetnick N.

    J Immunol. 1999 Aug 1;163(3):1696-703.PMID: 10415077 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.

    Schloot NC, Daniel D, Norbury-Glaser M, Wegmann DR.

    J Autoimmun. 1996 Jun;9(3):357-63.PMID: 8816971 [PubMed - indexed for MEDLINE]Related articles

    17.

    IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.

    Trembleau S, Penna G, Gregori S, Giarratana N, Adorini L.

    J Immunol. 2003 Jun 1;170(11):5491-501.PMID: 12759426 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543).

    Overbergh L, Decallonne B, Waer M, Rutgeerts O, Valckx D, Casteels KM, Laureys J, Bouillon R, Mathieu C.

    Diabetes. 2000 Aug;49(8):1301-7.PMID: 10923629 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).

    Quinn A, Sercarz EE.

    J Autoimmun. 1996 Jun;9(3):365-70.PMID: 8816972 [PubMed - indexed for MEDLINE]Related articles

    20.

    B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.

    Falcone M, Lee J, Patstone G, Yeung B, Sarvetnick N.

    J Immunol. 1998 Aug 1;161(3):1163-8.PMID: 9686575 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity